Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

New Study Connects Age-Related Gut Changes to Higher Disease Risk

May 15, 2026
Continue Reading
new-study-connects-age-related-gut-changes-to-higher-disease-risk
Posted inBiotechnology

Single mother must adapt swiftly — the survival of her colony depends on it

May 15, 2026
Continue Reading
single-mother-must-adapt-swiftly-—-the-survival-of-her-colony-depends-on-it
Posted inBiotechnology

Cancer-Linked Protein Plays Key Role in Tumor DNA Repair

May 15, 2026
Continue Reading
cancer-linked-protein-plays-key-role-in-tumor-dna-repair
Posted inBiotechnology

Single-Cell Atlas Reveals CD55+ Stem Cells’ Role in Atherosclerosis

May 15, 2026
Continue Reading
single-cell-atlas-reveals-cd55+-stem-cells’-role-in-atherosclerosis
Posted inBiotechnology

Immune Changes Detected After Ohio Train Derailment

May 15, 2026
Continue Reading
immune-changes-detected-after-ohio-train-derailment
Posted inBiotechnology

Leptin Epigenetics in Preterm Cord Blood Predict Obesity

May 15, 2026
Continue Reading
leptin-epigenetics-in-preterm-cord-blood-predict-obesity
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

fresh-off-$120m-raise,-ai-powered-terray-is-teaming-up-with-gilead-in-multi-pronged-r&d-pact
Posted inBiotechnology

Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact

December 17, 2024
Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy…
Read More
fierce-biotech’s-top-10-editor’s-picks-for-2024
Posted inBiotechnology

Fierce Biotech’s top 10 editor’s picks for 2024

December 17, 2024
The year kicked off with a flurry of dealmaking at the J.P. Morgan Healthcare Conference in January, and the pace…
Read More
merck-drops-tigit-asset-and-lag-3-program,-discontinuing-several-phase-3-trials
Posted inBiotechnology

Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials

December 16, 2024
Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline…
Read More
american-society-of-hematology-member-surveys-identify-barriers-to-improving-diversity-in-clinical-trials
Posted inResearch

American Society of Hematology member surveys identify barriers to improving diversity in clinical trials

December 16, 2024
A pair of assessments conducted by the American Society of Hematology (ASH) have helped identify roadblocks to improving diversity in…
Read More
boston-scientific-recalls-pacemakers-at-risk-of-triggering-permanent-safety-mode
Posted inMedical Technology

Boston Scientific recalls pacemakers at risk of triggering permanent safety mode

December 16, 2024
The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted…
Read More
ucb’s-orchestra-hits-dud-note:-novartis-partnered-parkinson’s-asset-fails-phase-2
Posted inBiotechnology

UCB’s orchestra hits dud note: Novartis-partnered Parkinson’s asset fails phase 2

December 16, 2024
UCB’s Novartis-partnered investigational small molecule has failed to improve symptoms of Parkinson’s disease in a phase 2a trial. The oral…
Read More
roche-mothballs-another-hemophilia-a-gene-therapy-under-spark-amid-plans-to-debut-new-hematologic-asset
Posted inBiotechnology

Roche mothballs another hemophilia A gene therapy under Spark amid plans to debut new hematologic asset

December 16, 2024
Following the apparent elimination of a late-stage gene therapy study last week, Swiss drug juggernaut Roche has confirmed that it’s…
Read More
candid-therapeutics-unwraps-three-new-collaborations-to-discover-and-develop-t-cell-engager-antibodies
Posted inBiotechnology

Candid Therapeutics unwraps three new collaborations to discover and develop T-cell engager antibodies

December 16, 2024
Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped…
Read More
bms-keeps-axing-deals-inked-under-old-leadership,-this-time-culling-cell-therapy-pacts-with-century,-immatics
Posted inBiotechnology

BMS keeps axing deals inked under old leadership, this time culling cell therapy pacts with Century, Immatics

December 16, 2024
Bristol Myers Squibb has terminated cell therapy pacts with two biotechs amid "ongoing portfolio prioritization efforts” within the Big Pharma,…
Read More
reviva’s-antipsychotic-shows-promise-against-schizophrenia-symptoms-in-year-long-study
Posted inBiotechnology

Reviva’s antipsychotic shows promise against schizophrenia symptoms in year-long study

December 16, 2024
In the wake of the approval Bristol Myers Squibb’s Cobenfy, it seems that news has ramped up in the schizophrenia…
Read More

Posts pagination

Previous page 1 … 1,826 1,827 1,828 1,829 1,830 … 1,836 Next page
You May Have Missed
neurovision-acquires-fellow-dx-player-durin-life-sciences
Posted inMedical Technology

NeuroVision acquires fellow dx player Durin Life Sciences

humacyte-cuts-spending,-staff-as-it-seeks-to-boost-sluggish-sales-for-its-off-the-shelf-artery-implant
Posted inMedical Technology

Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant

medtronic-to-shutter-santa-rosa-plant-as-it-restructures-cardiovascular-unit
Posted inMedical Technology

Medtronic to shutter Santa Rosa plant as it restructures cardiovascular unit

astrazeneca-pens-agentic-ai-licensing-deal-with-owkin
Posted inMedical Technology

AstraZeneca pens agentic AI licensing deal with Owkin

Privacy Policy    Terms

Scroll to Top